📊 Score Breakdown
Offering Ability
20
Cash Runway
40
Float Risk
45
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
40%
🔄 Reverse Split
55%
• 50-day avg $0.56 below $1 exchange minimum
📜 Warrant Exercise
25%
• Significant warrants: 18% of shares outstanding
📉 Score Deterioration
25%
• Score increased 11 points recently (worsening)
💹 Market Data
Market Cap$43.67M
Shares Outstanding108.83M
Float56.61M
Cash$24.95M
Debt$211.57M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 6.4% shares (2025Q4 vs prior)
76 institutional holders · 64.64M shares
#1
Coliseum Capital Management, LLC
46.86M shares
#2
WASATCH ADVISORS LP
5.12M shares
#3
VANGUARD GROUP INC
2.59M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.13M
Days to Cover4.1
% of Float3.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Jan 31, 2017
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for PRPL
📊 PRPL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 PRPL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.